Newsfeeds - Spark Newswire

1 minute read

Regeneron, Sanofi Announced Earlier , Dupixent Recommended For Expanded EU Approval By The CHMP To Treat Children As Young As Six Months Old With Severe Atopic Dermatitis

Today, 4:20 AM

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Dupixent® (dupilumab), recommending expanded approval in the European Union (EU) to treat severe atopic dermatitis in children 6 months to 5 years old who are candidates for systemic therapy.

REGN

1 minute read

Hopeful Golden Cross Forms On Sanofi’s Chart

By Benzinga Insights

Today, 4:20 AM

If history is any guide, there may be good fortune ahead for shares of Sanofi (NASDAQ:SNY). A so-called…

SNY

2 minute read

Innate Pharma Announces HSR Clearance Regarding Expansion Of Its Collaboration With Sanofi On NK Cell Engagers

By Benzinga Newsdesk

Today, 4:20 AM

Following expiration of Hart-Scott-Rodino waiting period regarding expansion of their collaboration on NK cell engagers, the licensing agreement between Sanofi and Innate is now effective. Innate Pharma SA

IPHA

2 minute read

Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot

By Vandana Singh

Today, 4:20 AM

Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand.

BNTX

1 minute read

News

Regulus Therapeutics Says Sanofi Delivered Written Notice To Co. To Terminate Second Amended, Restated Collaboration, License Agreement; Says In Accordance With Agreement, Termination Will Become Effective On Feb. 5, 2023

By Michael Horton

Today, 4:20 AM

-Reuters

RGLS

1 minute read

Sanofi Forecasts Foreign Exchange, Record Flu Vaccine Sales To Boost Q4 Earnings

By Vandana Singh

Today, 4:20 AM

As Sanofi SA (NASDAQ:SNY) schedules to report Q4 FY22 earnings early next month, it expects a positive currency impact in Q4 2022.…

SNY

1 minute read

News

Czech Veterinary Authority Reports Bird Flu Of H5n1 Type At Poultry Farm With 742,000 Chickens

By Benzinga Newsdesk

Today, 4:20 AM

-Reuters

BBIG

5 minute read

Vidprevtyn Beta Covid-19 Booster Vaccine, Developed By Sanofi And GSK, Approved For Use In Great Britain

By Benzinga Newsdesk

Today, 4:20 AM

https://www.gsk.com/en-gb/media/press-releases/vidprevtyn-beta-covid-19-booster-vaccine-approved-for-use-in-great-britain/ SARS-CoV-2 spike protein (B.1.351 strain) vaccine is the first and only protein-based variant

GSK

2 minute read

After Five Years Of Collaboration, Sanofi & Innate Pharma Expand Oncology Pact With Additional Programs

By Vandana Singh

Today, 4:20 AM

Innate Pharma SA (NASDAQ:IPHA) and Sanofi SA (NASDAQ:SNY) have expanded their collaboration, with Sanofi licensing a natural killer (NK) cell engager program…

IPHA

2 minute read

News

Sanofi and Innate Pharma Earlier Announced Expanded Collaboration for Natural Killer Cell Therapeutics in Oncology; Innate Will Receive €25M Upfront; Up to €1.35B in Milestones Plus Royalties on Potential Net Sales

By Charles Gross

Today, 4:20 AM

Sanofi (NASDAQ: SNY) and Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) announced today an expansion of their collaboration, with Sanofi licensing a natural killer (NK) cell engager program targeting B7H3 from Innate's ANKETTM (Antibody-based NK Cell Engager Therapeutics) platform.

IPHA